Biomea Fusion Stock Alpha and Beta Analysis
| BMEA Stock | USD 7.02 0.13 1.89% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biomea Fusion. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biomea Fusion over a specified time horizon. Remember, high Biomea Fusion's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biomea Fusion's market risk premium analysis include:
Beta 0.88 | Alpha (0.17) | Risk 4.83 | Sharpe Ratio 0.0117 | Expected Return 0.0566 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biomea |
Biomea Fusion Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biomea Fusion market risk premium is the additional return an investor will receive from holding Biomea Fusion long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biomea Fusion. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biomea Fusion's performance over market.| α | -0.17 | β | 0.88 |
Biomea Fusion expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biomea Fusion's Buy-and-hold return. Our buy-and-hold chart shows how Biomea Fusion performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Biomea Fusion Market Price Analysis
Market price analysis indicators help investors to evaluate how Biomea Fusion stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biomea Fusion shares will generate the highest return on investment. By understating and applying Biomea Fusion stock market price indicators, traders can identify Biomea Fusion position entry and exit signals to maximize returns.
Biomea Fusion Return and Market Media
The median price of Biomea Fusion for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 8.69 with a coefficient of variation of 19.82. The daily time series for the period is distributed with a sample standard deviation of 1.77, arithmetic mean of 8.91, and mean deviation of 1.53. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Biomea upgraded by analysts after FDA lifts clinical hold | 09/27/2024 |
2 | Biomea Fusion Inc Is Being Investigated For Possible Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm | 10/04/2024 |
3 | The Schall Law Firm Urges Shareholders To Join An Inquiry Into Biomea Fusion, Inc. For Securities Related Infractions | 10/11/2024 |
4 | Levi Korsinsky Investigates Possible Securities Fraud Violations by Biomea Fusion, Inc. | 10/14/2024 |
5 | Biomea Fusion, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi Korsinsky for Details - BMEA | 10/15/2024 |
6 | The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Biomea Fusion, Inc. For Securities Law Violations | 10/21/2024 |
7 | Biomea Fusion Inc Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Reach Out To The Schall Law Firm | 10/22/2024 |
8 | Biomea Fusion GAAP EPS of -0.91 beats by 0.04 | 10/29/2024 |
9 | The Schall Law Firm Urges Stockholders To Help With An Inquiry Into Biomea Fusion, Inc. For Securities Law Violations | 10/30/2024 |
10 | Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635 | 11/01/2024 |
11 | The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Biomea Fusion, Inc. For Securities Law Violations | 11/04/2024 |
12 | Biomea Fusion, Inc. Receives Consensus Recommendation of Buy from Brokerages - MarketBeat | 11/21/2024 |
About Biomea Fusion Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biomea or other stocks. Alpha measures the amount that position in Biomea Fusion has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2024 (projected) | Current Ratio | 38.08 | 6.17 | 7.45 | Net Debt To EBITDA | 4.17 | 1.34 | 1.27 |
Biomea Fusion Upcoming Company Events
As portrayed in its financial statements, the presentation of Biomea Fusion's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomea Fusion's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biomea Fusion's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biomea Fusion. Please utilize our Beneish M Score to check the likelihood of Biomea Fusion's management manipulating its earnings.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Biomea Fusion
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Biomea Fusion Backtesting, Biomea Fusion Valuation, Biomea Fusion Correlation, Biomea Fusion Hype Analysis, Biomea Fusion Volatility, Biomea Fusion History and analyze Biomea Fusion Performance. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Biomea Fusion technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.